Exhibit 99.1
Commission File Number 001-31914
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
CHINA LIFE INSURANCE COMPANY LIMITED
(A joint stock limited company incorporated in the People’s Republic of China with limited liability)
(the “Company”)
(Stock Code: 2628)
ANNOUNCEMENT OF UNAUDITED INTERIM RESULTS
FOR THE SIX MONTHS ENDED 30 JUNE 2013
CHAIRMAN’S STATEMENT
In the first half of 2013, the global economic recovery experienced difficulties, and the economic development in China faced intricate and complicated situations that had not been seen for years. It is a difficult period for the life insurance industry. Faced with this severe and complicated business environment, all employees of the Company firmly adhered to the keynote of “tackling difficulties, making steady progress and striving for development”, focused on the principle of “steady growth, adjusting structure, transforming model and preventing risks”, pushed forward and implemented the “innovation-driven development strategy”, responded to various risks and challenges in an efficient and effective manner, and dealt with various tasks properly. As a result, the Company achieved steady growth in its business and its market leading position was consolidated.
As at the end of the Reporting Period, the Company’s total assets reached RMB1,984,035 million, an increase of 4.5% from the end of 2012; embedded value was RMB363,359 million, an increase of 7.6% from the end of 2012; and new business value for the six months ended 30 June 2013 was RMB12,589 million, a 0.8% increase year-on-year. The Company’s market share1 in the first half of 2013 was approximately 32.5%, maintaining a leading position in life insurance market. During the Reporting Period, the Company’s total revenue was RMB247,548 million, a 18.7% increase year-on-year; net profit attributable to equity holders of the Company was RMB16,198 million, a 68.1% increase year-on-year; and earnings per share (basic and diluted) were RMB0.57, a 68.1% increase year-on-year. As at 30 June 2013, the Company’s solvency ratio was 237.90%.
1 | Calculated according to the premium data of life insurance companies in the first half of 2013 released by the China Insurance Regulatory Commission (the “CIRC”). |
Commission File Number 001-31914
During the Reporting Period, the total amount of insurance benefits and claims paid by the Company reached RMB83,991 million, which further highlighted the Company’s role in providing economic compensation and insurance protection to the society. While fulfilling its obligations under insurance policies, the Company actively undertook its corporate social responsibility. Relying on its competitive advantages in professionalism and business scale, the Company continued to develop policy businesses including New Village Cooperative Medical Insurance, New Rural Pension Insurance, Basic Medical Insurance Program for Urban and Township Residents, Rural Medical Assistance Insurance, as well as Rural Micro-insurance business. The Company also made a good start in the Supplementary Major Medical Insurance Business for Urban and Rural Residents (the “Supplementary Major Medical Insurance Business”) by winning bids in a number of provinces, cities and districts. In addition, the Company provided insurance coverage for the astronauts of Shenzhou-10 and approximately 210,000 college-graduate village officials. The Company actively participated in public welfare and charitable undertakings. During the Reporting Period, the Company donated RMB10 million through the China Life Foundation to Sichuan Charity Federation to provide funding for the construction of schools and health stations in Ya’an earthquake areas, continued to provide support for Wenchuan earthquake orphans, Yushu earthquake orphans and Zhouqu mudslide orphans, embarked on the charity event of “Relay for Love, Sailing for Dream – Dreams of Earthquake Orphans Come True” to help them realize their wishes and dreams. The Company also made donations to relevant foundations to provide subsidies for particularly poor police families, donated sports facilities, such as basketball stands, to China Life primary schools and other schools that participated in the “Yao Foundation Hope Primary School Basketball Season”, and provided funding for the construction of two day care centers in Urumqi and provided relief to poverty-stricken patients with serious diseases.
In June 2013, the Company completed the procedures for the change of the Board Secretary. Ms. Liu Yingqi resigned as the Board Secretary due to work adjustment. During her tenure as the Board Secretary, Ms Liu Yingqi worked diligently and fully fulfilled her duties and obligations, and made substantial and outstanding achievements in the promotion of the development of corporate governance, regularization of operation of the Board of Directors, enhancement of information disclosure standard and strengthening of the management of investor relations. The Company would like to express its gratitude to Ms Liu Yingqi for her significant contribution.
2
Commission File Number 001-31914
Currently, the development environment both within and outside China remains complicated. The life insurance industry is in a period of “slowdown in growth, adjustment in structure and transformation in the development model” and is facing various difficulties. Nevertheless, China’s overall economic development remains stable, and the life insurance industry continues to see tremendous development potentials. Recently, with the issuance of the “Guiding Opinions on Financial Support for Adjusting, Transforming and Upgrading the Economic Structure” by the State Council and the issuance of policies including the reform measures on traditional life insurance premium rates by the CIRC, the width and depth of the services provided by the insurance industry for the economic and social development will be further expanded. The Company will adhere to the keynote of “tackling difficulties, making steady progress and striving for development”, focus on both scale and profit, and place emphasis upon the growth of business value while maintaining the steady growth of its business. The Company will continue to implement the “innovation-driven development strategy” with great effort, strengthen the innovation in its systems and mechanisms, step up its efforts on the transformation of its products, create new ways and means of its services to customers and further improve the professional operation of the Company, thus continuously enhancing its vitality. The Company will promote the culture of bottom-line thinking and enhance risk prevention so as to ensure its stable operation. The Company will also allocate greater resources to local branches to further stimulate their vitality.
China Life is in a key phase of accelerating the transformation of its development model. Maintaining the Company’s market leading position and striving to increase its business value are not only the expectation of shareholders, customers and society towards us, but also the bounden responsibility of all our employees. We will carry forward the good tradition fostered for 10 years since our public listing, make good use of our unique advantages, implement the “innovation-driven development strategy” in great depth, work together with full dedication and tackle difficulties without hesitation, tirelessly striving towards the goal of offering better service to the customers of the Company and providing long- term and stable returns to our shareholders.
3
Commission File Number 001-31914
MANAGEMENT DISCUSSION AND ANALYSIS2
I | Overview of Operations in the First Half of 2013 |
In the first half of 2013, the Company closely followed the development trend of the life insurance market and took effective measures to actively respond to the new changes in market competition. As a result, the Company achieved a good growth in the premiums earned and further consolidated its market leading position. During the Reporting Period, the Company’s net premiums earned was RMB200,844 million, an increase of 8.7% as compared to the corresponding period of 2012; net profit attributable to equity holders of the Company was RMB16,198 million, a 68.1% increase year- on-year. The new business value for the six months ended 30 June 2013 was RMB12,589 million, a 0.8% increase year-on-year. As at the end of the Reporting Period, the Company’s embedded value was RMB363,359 million, a 7.6% increase from the end of 2012. First-year premiums increased by 9.2% as compared to the corresponding period of 2012, and the percentage of first- year regular premiums with 10 years or longer payment duration in first-year regular premiums increased to 41.79% in the first half of 2013 from 37.57% in the corresponding period of 2012. Renewal premiums increased by 8.4% as compared to the corresponding period of 2012, and the percentage of renewal premiums in gross written premiums decreased to 55.25% in the first half of 2013 from 55.88% in the corresponding period of 2012. Short-term accident insurance premiums increased by 14.1% as compared to the corresponding period of 2012, and the percentage of short- term accident insurance premiums in short-term insurance premiums increased to 61.00% in the first half of 2013 from 60.59% in the corresponding period of 2012. First-year premiums earned through bancassurance channel increased by 11.1% as compared to the corresponding period of 2012, and first-year premiums earned through exclusive individual agent channel remained stable as compared to the corresponding period of 2012. Due to the impact of the macro-economic environment, bancassurance regulations, and financial products such as wealth management products offered by banks, there was a significant negative growth in first-year regular premiums earned through bancassurance channel, which resulted in first-year regular premiums decreasing by 11.7% as compared to the corresponding period of 2012 and the percentage of first-year regular premiums in first-year premiums decreasing to 30.28% in the first half of 2013 from 37.43% in the corresponding period of 2012. As at 30 June 2013, the number of in-force policies increased by 4.0% from the end of 2012; the Policy Persistency Rate (14 months and 26 months)3 reached 90.00% and 88.75%, respectively; and the Surrender Rate4 was 2.05%, a 0.67 percentage point increase as compared to the corresponding period of 2012.
2 | Financial results of the Reporting Period are unaudited. |
3 | The Persistency Rate for long-term individual policy is an important operating performance indicator for life insurance companies It measures the ratio of in-force policies in a pool of policies after a certain period of time It refers to the proportion of policies that are still effective during the designated month in the pool of policies whose issue date was 14 or 26 months ago. |
4 | Surrender Rate = Surrender payment/(Liability of long-term insurance contracts at the beginning of the period + Premium of long-term insurance contracts) |
4
Commission File Number 001-31914
With respect to the exclusive individual agent channel, the Company achieved steady growth in its business and maintained a stable business scale. With the continuous promotion of the “effective expansion” strategy for team building, the size of the sales force remained stable, and the overall quality of the sales force continued to improve. The Company made progress in enhancing the professional standards of the channel with effective product strategy and sales planning, and the new E-China Life mobile marketing tool was further integrated into the daily sales activities of the exclusive individual agents. As at the end of the Reporting Period, the Company had a total of 684,000 exclusive individual agents.
With respect to the group insurance channel, the Company achieved steady growth in premiums, and further expanded its advantage as a market leader. Moreover, the Company actively provided services for the economic and social development, and participated in the building of the social security system. The Company continued to engage in the policy businesses including insurance for college-graduate village officials, and provided personal insurance for the astronauts of Shenzhou-10. The Company focused on the development of sales teams in group insurance channel, and strived to improve the marketing capability of direct sales representatives and the satisfaction of group customers. As at the end of the Reporting Period, the Company had approximately 16,000 direct sales representatives.
With respect to the bancassurance channel, while there was a slowdown in overall business growth of the bancassurance market, the Company actively strengthened its efforts in product innovation, enhanced agency channel cooperation, improved service and support, and enhanced the quality of the sales team. As a result, the Company’s business in bancassurance channel achieved a faster growth as compared to the industry average. As at the end of the Reporting Period, the number of intermediary bancassurance outlets was 88,000, with a total of 56,000 sales representatives.
In the first half of 2013, the monetary market fluctuated dramatically, government bond performances were lackluster, the debenture bond market expanded, and the SSE Composite Index continued to decline after hitting a high point. The Company flexibly responded to changes in the capital market, seized opportunities presented by the new investment policies, diversified insurance investment types and channels, strengthened its investment capability building and risk management, and constantly improved its portfolio allocation. With respect to traditional investments, the Company seized the periodic opportunities for allocation in the deposit market, and the proportion of term deposits increased to 37.23% from 35.80% as at the end of 2012. Based on the characteristics of performance differentiation in the bond market, the Company optimized its bond portfolio, and continued to increase its allocation in senior credit types of bonds. The proportion of debt securities slightly decreased to 46.01% from 46.24% as at the end of 2012. The Company grasped the opportunities brought about by the fluctuation in the equity market, realized its gains in a timely manner, and further controlled the risk associated with equity securities. The proportion of equity securities decreased to 8.02% from 9.20% as at the end of 2012. With respect to alternative
5
Commission File Number 001-31914
investments, the Company strengthened the professional management of its alternative investments and intensified its efforts to promote such investments. The Company invested in China Life Suzhou Urban Development Industry Investment Fund with a contract amount of RMB5 billion. The Company also invested in the first infrastructure equity investment plan named “Equity Investment Plan for PetroChina Pipeline Project of the West Natural Gas Lines No.1 and No.2” with an investment amount of RMB4.8 billion. The Company promoted infrastructure and real estate debt investment plans, with an accumulated investment amount of RMB45.5 billion. The Company promoted investment in financial products, such as trust schemes, wealth management products and special asset management plans, with a total amount of approximately RMB3.7 billion. The duration of these alternative investment assets effectively matched the duration of the Company’s liabilities, and these alternative investments promoted the diversification of the Company’s portfolio, which are therefore conducive to the long-term and stable investment returns of the Company. As at the end of the Reporting Period, the Company’s investment assets reached RMB1,855,519 million, an increase of 3.6% from the end of 2012. During the Reporting Period, interest income increased steadily, and net investment yield5 was 4.42%. Incomes from buy-sale price differential grew significantly, and the impairment losses of assets decreased notably, as a result of which the gross investment yield6 was 4.96% and gross investment yield including share of profit of associates7 was 5.05%. The comprehensive investment yield taking into account the current net fair value changes of available- for-sale securities recognized in other comprehensive income8 was 4.27%.
5 | Net investment yield = {[(Investment income + Rental income from investment properties – Business tax and extra charges for investment) / ((Investment assets at the beginning of the period + Investment assets at the end of the period) / 2)]/181} × 365 |
6 | Gross investment yield = {[(Investment income + Net realised gains/(losses) and impairment on financial assets + Net fair value gains/(losses) through profit or loss + Total income from investment properties – Business tax and extra charges for investment) / ((Investment assets at the beginning of the period + Investment assets at the end of the period) / 2)]/181} × 365 |
7 | Gross investment yield including share of profit of associates = {[(Investment income + Net realised gains/(losses) and impairment on financial assets + Net fair value gains/(losses) through profit or loss + Total income from investment properties – Business tax and extra charges for investment + Share of profit of associates) / ((Investment assets at the beginning of the period + Investments in associates at the beginning of the period + Investment assets at the end of the period + Investments in associates at the end of the period) / 2)]/181} × 365 |
8 | Comprehensive investment yield = {[(Investment income + Net realised gains/(losses) and impairment on financial assets + Net fair value gains/(losses) through profit or loss + Current net fair value changes of available-for-sale securities recognized in other comprehensive income + Total income from investment properties – Business tax and extra charges for investment) / ((Investment assets at the beginning of the period + Investment assets at the end of the period) / 2) ]/181} × 365 |
6
Commission File Number 001-31914
In the first half of 2013, the Company implemented the “innovation-driven development strategy” with great effort, made progress in products innovation, and introduced a number of new products including Ruixin product package, Xinfeng and Xinyu product package in its exclusive individual agent channel, bancassurance channel and group insurance channel, thus providing support to its business development. The Company took a new step in technological innovation, and further expanded the features offering in the E-China Life mobile marketing system. The Company completed the promotion of its online national platform for claims settlement, as a result of which the efficiency of claims settlement was significantly enhanced. The Company actively expanded the E-service for insurance policies in order to continuously improve the quality of insurance policy service. The Company entered into a new stage of service innovation, optimized its policy loan service and embarked on a pilot program of integrated customer service system, with a view to improving its customer experience. The Company further increased the return visit to new policyholders of individual long-term life insurance products, actively promoted the business model of centralised operation of 95519 telephone centre during night time, upgraded its call center services, further improved the mechanism for handling customer complaints, kept on enhancing its notification service level, and continued to conduct the “Hand in Hand” series of customer service activities and the “China Life Customer Day” activities.
The Company continued to comply with Section 404 of the U.S Sarbanes-Oxley Act. Meanwhile, it carried out the work for the compliance with standard systems of corporate internal control by following the “Standard Regulations on Corporate Internal Control” and the “Implementation Guidelines for Corporate Internal Control” jointly issued by five PRC ministries including the Ministry of Finance and the “Basic Standards of Internal Control for Insurance Companies” issued by the CIRC. With the promotion of its internal control implementation manual which covers all aspects of the Company, and the comprehensive assessment on its internal control functions, the Company further improved its internal control system. By exploring and using the internal control management information system which covers the entire process of internal control management, the Company significantly improved the efficiency and effectiveness of its internal control management. The Company continuously complied with the “Guidelines for the Implementation of Comprehensive Risk Management of Personal Insurance Companies” issued by the CIRC, carried out the construction and implementation of the risk tolerance system, established a management mechanism with respect to the formation, execution, transmission, and re-examination and adjustment of risk tolerance, and compiled the “Statement on Risk Tolerance” which has been approved by the Board of Directors. The Company strengthened its efforts in risk early- warning and risk classification management, and intensified its control over key risks, thus forming a standardized and systematic early-warning system. Based upon the principle of integrity established for years, the Company formally built up the core value of the corporate culture with emphasis on “honesty, integrity, gratitude, achievement” in the sales force, which reflected the harmony and unity between the integrity practice and the long-term objectives of the Company. The Company also set up a system for the establishment of integrity culture, conducted an activity titled “Integrity-I Do First” within its organization for six consecutive years, carried out integrity compliance education and training, and took incentive measures for integrity, so as to promote the positive development and quality improvement of its teams. The Company expanded the coverage of sales risk early-warning and monitoring in channels, and continued to improve its ability to monitor and control sales risks on a daily basis. The Company also continued to carry out the comprehensive control of misleading sales, intensified the special control on key risks in sales sector, and made efforts to push forward the establishment of a long-term effective mechanism for the regulation and control of sales risks.
7
Commission File Number 001-31914
II Analysis of Major Items of Consolidated Statement of Comprehensive Income
1. | Total Revenues |
RMB million | ||||||||
January to June 2013 | January to June 2012 | |||||||
Net premiums earned | 200,844 | 184,739 | ||||||
Individual life insurance business | 191,104 | 176,483 | ||||||
Group life insurance business | 1,023 | 315 | ||||||
Short-term insurance business | 8,197 | 7,941 | ||||||
Supplementary major medical insurance business | 520 | — | ||||||
Investment income | 40,103 | 35,303 | ||||||
Net realised gains and impairment on financial assets | 3,922 | (13,114 | ) | |||||
Net fair value gains through profit or loss | 918 | 177 | ||||||
Other income | 1,761 | 1,495 | ||||||
|
|
|
| |||||
Total | 247,548 | 208,600 | ||||||
|
|
|
| |||||
Net Premiums Earned |
(1) | Individual Life Insurance Business |
During the Reporting Period, net premiums earned from individual life insurance business increased by 8.3% year-on-year. This was primarily due to the Company’s increased efforts in business development.
8
Commission File Number 001-31914
(2) | Group Life Insurance Business |
During the Reporting Period, net premiums earned from group life insurance business increased by 224.8% year-on-year. This was primarily due to an increase in premiums from group annuity business.
(3) | Short-term Insurance Business |
During the Reporting Period, net premiums earned from short-term insurance business increased by 3.2% year-on-year. This was primarily due to the Company’s increased efforts in the development of accident insurance business.
(4) | Supplementary Major Medical Insurance Business |
During the Reporting Period, the change of net premiums earned from supplementary major medical insurance business was primarily due to the fact that the Company newly developed supplementary major medical insurance business in the first half of 2013.
Gross written premiums categorized by business:
RMB million | ||||||||
January to June 2013 | January to June 2012 | |||||||
Individual Life Insurance Business | 191,186 | 176,499 | ||||||
First-year business | 78,881 | 72,885 | ||||||
Single | 54,699 | 45,486 | ||||||
First-year regular | 24,182 | 27,399 | ||||||
Renewal business | 112,305 | 103,614 | ||||||
Group Life Insurance Business | 1,027 | 316 | ||||||
First-year business | 1,031 | 316 | ||||||
Single | 1,016 | 315 | ||||||
First-year regular | 15 | 1 | ||||||
Renewal business | (4 | ) | — | |||||
Short-term Insurance Business | 9,770 | 8,623 | ||||||
Short-term accident insurance business | 5,960 | 5,225 | ||||||
Short-term health insurance business | 3,810 | 3,398 | ||||||
Supplementary Major Medical Insurance Business | 1,268 | — | ||||||
|
|
|
| |||||
Total | 203,251 | 185,438 | ||||||
|
|
|
|
9
Commission File Number 001-31914
Gross written premiums categorized by channel:
RMB million | ||||||||
January to June 2013 | January to June 20122 | |||||||
Exclusive Individual Agent Channel | 116,154 | 105,713 | ||||||
First-year business of long-term insurance | 19,522 | 19,554 | ||||||
Single | 157 | 208 | ||||||
First-year regular | 19,365 | 19,346 | ||||||
Renewal business | 93,742 | 83,260 | ||||||
Short-term insurance business | 2,890 | 2,899 | ||||||
Group Insurance Channel | 8,989 | 6,992 | ||||||
First-year business of long-term insurance | 1,840 | 955 | ||||||
Single | 1,755 | 870 | ||||||
First-year regular | 85 | 85 | ||||||
Renewal business | 318 | 341 | ||||||
Short-term insurance business | 6,831 | 5,696 | ||||||
Bancassurance Channel | 76,490 | 72,489 | ||||||
First-year business of long-term insurance | 58,409 | 52,591 | ||||||
Single | 53,793 | 44,716 | ||||||
First-year regular | 4,616 | 7,875 | ||||||
Renewal business | 18,035 | 19,874 | ||||||
Short-term insurance business | 46 | 24 | ||||||
Other Channels1 | 1,618 | 244 | ||||||
First-year business of long-term insurance | 141 | 101 | ||||||
Single | 10 | 7 | ||||||
First-year regular | 131 | 94 | ||||||
Renewal business | 206 | 139 | ||||||
Short-term insurance business | 3 | 4 | ||||||
Supplementary major medical insurance business | 1,268 | — | ||||||
|
|
|
| |||||
Total | 203,251 | 185,438 | ||||||
|
|
|
|
Notes:
1. | Other channels mainly include supplementary major medical insurance business and telephone sales, etc. |
2. | In the first half of 2013, the Company’s channel premium breakdown was presented based on the separate groups of sales personnels belonging to exclusive individual agent team, direct sales representatives, bancassurance sales team, and other distribution channels respectively, with the corresponding data for the first half of 2012 adjusted accordingly. |
10
Commission File Number 001-31914
Investment Income
RMB million | ||||||||
January to June 2013 | January to June 2012 | |||||||
Investment income from securities at fair value through profit or loss | 787 | 836 | ||||||
Investment income from available-for-sale securities | 9,611 | 10,664 | ||||||
Investment income from held-to-maturity securities | 10,951 | 6,330 | ||||||
Investment income from bank deposits | 15,937 | 14,959 | ||||||
Investment income from loans | 2,642 | 2,027 | ||||||
Other investment income | 175 | 487 | ||||||
|
|
|
| |||||
Total | 40,103 | 35,303 | ||||||
|
|
|
|
(1) | Investment Income from Securities at Fair Value through Profit or Loss |
During the Reporting Period, investment income from securities at fair value through profit or loss decreased by 5.9% year-on-year. This was primarily due to a decrease in the volume of securities at fair value through profit or loss as compared to the corresponding period of last year.
(2) | Investment Income from Available-for-Sale Securities |
During the Reporting Period, investment income from available-for-sale securities decreased by 9.9% year-on-year. This was primarily due to the Company’s decreased allocation in available-for-sale securities.
(3) | Investment Income from Held-to-Maturity Securities |
During the Reporting Period, investment income from held-to-maturity securities increased by 73.0% year-on-year. This was primarily due to an increase in interest income resulting from the Company’s increased allocation in held-to-maturity securities.
(4) | Investment Income from Bank Deposits |
During the Reporting Period, investment income from bank deposits increased by 6.5% year-on-year. This was primarily due to the increased volume of deposits resulting from the Company’s increased allocation in deposits.
(5) | Investment Income from Loans |
During the Reporting Period, investment income from loans increased by 30.3% year-on- year. This was primarily due to the increased volume of policy loans and debt investment plans.
11
Commission File Number 001-31914
Net Realised Gains and Impairment on Financial Assets
During the Reporting Period, net realised gains and impairment on financial assets increased significantly year-on-year. This was primarily due to an increase in income from the buy-sale price differential in the trading of available-for-sale equity securities, and a decrease in impairment losses of available-for-sale equity securities.
Net Fair Value Gains through Profit or Loss
During the Reporting Period, net fair value gains through profit or loss increased by 418.6% year-on-year. This was primarily due to the fluctuation in the value of financial instruments at fair value through profit or loss.
Other Income
During the Reporting Period, other income increased by 17.8% year-on-year. This was primarily due to an increase in commission fees earned from China Life Property and Casualty Insurance Company Limited.
2. | Benefits, Claims and Expenses |
RMB million | ||||||||
January to | January to | |||||||
June 2013 | June 2012 | |||||||
Insurance benefits and claims expenses | 189,247 | 168,414 | ||||||
Individual life insurance business | 183,556 | 164,146 | ||||||
Group life insurance business | 1,003 | 258 | ||||||
Short-term insurance business | 4,137 | 4,010 | ||||||
Supplementary major medical insurance business | 551 | — | ||||||
Investment contract benefits | 985 | 968 | ||||||
Policyholder dividends resulting from participation in profits | 9,777 | 2,495 | ||||||
Underwriting and policy acquisition costs | 13,800 | 14,569 | ||||||
Finance costs | 1,935 | 891 | ||||||
Administrative expenses | 10,817 | 9,813 | ||||||
Other expenses | 2,021 | 1,614 | ||||||
Statutory insurance fund contribution | 385 | 345 | ||||||
|
|
|
| |||||
Total | 228,967 | 199,109 | ||||||
|
|
|
|
12
Commission File Number 001-31914
Insurance Benefits and Claims Expenses
(1) | Individual Life Insurance Business |
During the Reporting Period, insurance benefits and claims expenses attributable to individual life insurance business increased by 11.8% year-on-year. This was primarily due to an increase in life insurance death and other benefits.
(2) | Group Life Insurance Business |
During the Reporting Period, insurance benefits and claims expenses attributable to group life insurance business increased by 288.8% year-on-year. This was primarily due to a growth in increase in insurance contracts liabilities from group business.
(3) | Short-term Insurance Business |
During the Reporting Period, insurance benefits and claims expenses attributable to short-term insurance business increased by 3.2% year-on-year. This was primarily due to an increase in accident insurance claims payment resulting from the increase in business volume.
(4) | Supplementary Major Medical Insurance Business |
During the Reporting Period, the change of insurance benefits and claims expenses attributable to supplementary major medical insurance business was primarily due to the fact that the Company newly developed supplementary major medical insurance business in the first half of 2013.
Investment Contract Benefits
During the Reporting Period, investment contract benefits increased by 1.8% year-on-year. This was primarily due to an increase in interest payments.
Policyholder Dividends Resulting from Participation in Profits
During the Reporting Period, policyholder dividends resulting from participation in profits increased by 291.9% year-on-year. This was primarily due to an increase in investment yields for participating products.
Underwriting and Policy Acquisition Costs
During the Reporting Period, underwriting and policy acquisition costs decreased by 5.3% year-on-year. This was primarily due to a decrease in policy acquisition fees and overriding commission costs.
13
Commission File Number 001-31914
Finance Costs
During the Reporting Period, finance costs increased by 117.2% year-on-year. This was primarily due to an increase in interest payments for subordinated term debts.
Administrative Expenses
During the Reporting Period, administrative expenses increased by 10.2% year-on-year. This was primarily due to the fact that the Company increased its costs on employee team building so as to enhance its ability for sustainable development.
Other Expenses
During the Reporting Period, other expenses increased by 25.2% year-on-year. This was primarily due to an increase in foreign currency losses.
3. | Profit before Income Tax |
RMB million | ||||||||
January to June 2013 | January to June 2012 | |||||||
Individual life insurance business | 18,045 | 9,015 | ||||||
Group life insurance business | 129 | 88 | ||||||
Short-term insurance business | 248 | 247 | ||||||
Supplementary major medical insurance business | (75 | ) | — | |||||
Other | 1,810 | 1,662 | ||||||
|
|
|
| |||||
Total | 20,157 | 11,012 | ||||||
|
|
|
|
(1) | Individual Life Insurance Business |
During the Reporting Period, profit before income tax of the Company in the individual life insurance business increased by 100.2% year-on-year. This was primarily due to an increase in investment income and a decrease in impairment losses in the individual life insurance segment.
(2) | Group Life Insurance Business |
During the Reporting Period, profit before income tax of the Company in the group life insurance business increased by 46.6% year-on-year. This was primarily due to an increase in investment income and a decrease in impairment losses in the group life insurance segment.
14
Commission File Number 001-31914
(3) | Short-term Insurance Business |
During the Reporting Period, profit before income tax of the Company in the short-term insurance business increased by 0.4% year-on-year. This was primarily due to a steady growth of short-term insurance business.
(4) | Supplementary Major Medical Insurance Business |
The Company newly developed supplementary major medical insurance business in the first half of 2013, with a premiums earned of RMB1,268 million and reserves drawn of RMB1,157 million, as a result of which the profit before income tax in the supplementary major medical insurance business was RMB-75 million.
4. | Income Tax |
During the Reporting Period, income tax of the Company was RMB3,829 million, a 201.3% increase year-on-year. This was primarily due to the impact of the taxable income and the deferred tax.
5. | Net Profit |
During the Reporting Period, net profit attributable to equity holders of the Company was RMB16,198 million, a 68.1% increase year-on-year. This was primarily due to an increase in investment income and a decrease in impairment losses.
III. | Analysis of Major Items of Consolidated Statement of Financial Position |
1. | Major Assets |
RMB million | ||||||||
As at 30 June 2013 | As at 31 December 2012 | |||||||
Investment assets | 1,855,519 | 1,790,838 | ||||||
Term deposits | 690,829 | 641,080 | ||||||
Held-to-maturity securities | 477,350 | 452,389 | ||||||
Available-for-sale securities | 481,537 | 506,416 | ||||||
Securities at fair value through profit or loss | 43,737 | 34,035 | ||||||
Securities purchased under agreements to resell | 6,109 | 894 | ||||||
Cash and cash equivalents | 51,113 | 69,452 | ||||||
Loans | 97,339 | 80,419 | ||||||
Statutory deposits-restricted | 6,153 | 6,153 | ||||||
Investment Properties | 1,352 | — | ||||||
Other assets | 128,516 | 108,078 | ||||||
|
|
|
| |||||
Total | 1,984,035 | 1,898,916 | ||||||
|
|
|
|
15
Commission File Number 001-31914
Term Deposits
As at the end of the Reporting Period, term deposits increased by 7.8% from the end of 2012. This was primarily due to the Company’s increased allocation in ordinary term deposits.
Held-to-Maturity Securities
As at the end of the Reporting Period, held-to-maturity securities increased by 5.5% from the end of 2012. This was primarily due to the fact that the Company increased the volume of held-to-maturity assets appropriately in light of market conditions.
Available-for-Sale Securities
As at the end of the Reporting Period, available-for-sale securities decreased by 4.9% from the end of 2012. This was primarily due to the Company’s decreased allocation in equity assets in light of market conditions.
Securities at Fair Value through Profit or Loss
As at the end of the Reporting Period, securities at fair value through profit or loss increased by 28.5% from the end of 2012. This was primarily due to the Company’s increased allocation in securities at fair value through profit or loss in light of market conditions.
Cash and Cash Equivalents
As at the end of the Reporting Period, cash and cash equivalents decreased by 26.4% from the end of 2012. This was primarily due to the needs for liquidity management.
Loans
As at the end of the Reporting Period, loans increased by 21.0% from the end of 2012. This was primarily due to an increase in the volume of policy loans, as well as the Company’s increased allocation in debt investment plans.
16
Commission File Number 001-31914
As at the end of the Reporting Period, our investment assets are categorized as below in terms of asset classes:
RMB million | ||||||||||||||||
As at 30 June 2013 | As at 31 December 2012 | |||||||||||||||
Amount | Percentage | Amount | Percentage | |||||||||||||
Cash and cash equivalents | 51,113 | 2.75 | % | 69,452 | 3.88 | % | ||||||||||
Term deposits | 690,829 | 37.23 | % | 641,080 | 35.80 | % | ||||||||||
Bonds | 853,513 | 46.00 | % | 828,098 | 46.24 | % | ||||||||||
Funds | 56,741 | 3.06 | % | 59,207 | 3.30 | % | ||||||||||
Common stocks | 83,120 | 4.48 | % | 102,089 | 5.70 | % | ||||||||||
Others | 120,203 | 6.48 | % | 90,912 | 5.08 | % | ||||||||||
|
|
|
|
|
|
|
| |||||||||
Total | 1,855,519 | 100 | % | 1,790,838 | 100 | % | ||||||||||
|
|
|
|
|
|
|
|
2. | Major Liabilities |
RMB million | ||||||||
As at 30 | As at 31 | |||||||
June 2013 | December 2012 | |||||||
Insurance contracts | 1,459,892 | 1,384,537 | ||||||
Investment contracts | 65,512 | 66,639 | ||||||
Policyholder dividends payable | 46,218 | 44,240 | ||||||
Bonds payable | 67,983 | 67,981 | ||||||
Securities sold under agreements to repurchase | 57,426 | 68,499 | ||||||
Annuity and other insurance balances payable | 26,010 | 16,890 | ||||||
Deferred tax liabilities | 9,534 | 7,834 | ||||||
Other liabilities | 18,732 | 19,195 | ||||||
|
|
|
| |||||
Total | 1,751,307 | 1,675,815 | ||||||
|
|
|
|
Insurance Contracts
As at the end of the Reporting Period, liabilities of insurance contracts increased by 5.4% from the end of 2012. This was primarily due to new insurance business and the accumulation of insurance liabilities from renewal business. As at the balance sheet date, the Company’s reserves for insurance contracts satisfied the liability adequacy testing.
17
Commission File Number 001-31914
Investment Contracts
As at the end of the Reporting Period, account balance of investment contracts decreased by 1.7% from the end of 2012. This was primarily due to a decrease in the account volume of some investment contracts products.
Policyholder Dividends Payable
As at the end of the Reporting Period, policyholder dividends payable increased by 4.5% from the end of 2012. This was primarily due to an increase in investment yields for participating products.
Bonds Payable
As at the end of the Reporting Period, bonds payable remain stable as compared to the end of 2012. This was primarily due to the fact that no subordinated term debts were issued by the Company in the first half of 2013.
Securities Sold under Agreements to Repurchase
As at the end of the Reporting Period, securities sold under agreements to repurchase decreased by 16.2% from the end of 2012. This was primarily due to the needs for liquidity management.
Annuity and Other Insurance Balances Payable
As at the end of the Reporting Period, annuity and other insurance balances payable increased by 54.0% from the end of 2012. This was primarily due to the accumulation of insurance liabilities.
Deferred Tax Liabilities
As at the end of the Reporting Period, deferred tax liabilities increased by 21.7% from the end of 2012. This was primarily due to the impact of a decrease in deductible temporary differences.
3. | Equity Holders’ Equity |
As at the end of the Reporting Period, equity holders’ equity was RMB230,643 million, a 4.3% increase from the end of 2012. This was primarily due to the impact of net profit during the Reporting Period.
18
Commission File Number 001-31914
IV | Analysis of Cash Flows |
1. | Liquidity Sources |
Our principal cash inflows come from insurance premiums, deposits from investment contracts, proceeds from sales and maturity of financial assets, and investment income. The primary liquidity risks with respect to these cash flows are the risk of early withdrawals by contract holders and policyholders, as well as the risks of default by debtors, interest rate changes and other market volatilities. We closely monitor and manage these risks.
Our cash and bank deposits can provide us with a source of liquidity to meet normal cash outflows. As at the end of the Reporting Period, the amount of cash and cash equivalents was RMB51,113 million. In addition, substantially all of our term deposits with banks allow us to withdraw funds on deposit, subject to a penalty interest charge. As at the end of the Reporting Period, the amount of term deposits was RMB690,829 million.
Our investment portfolio also provides us with a source of liquidity to meet unexpected cash outflows. As at the end of the Reporting Period, investments in debt securities had a fair value of RMB857,022 million, while investments in equity securities had a fair value of RMB148,828 million. We are also subject to market liquidity risk due to the large size of our investments in some of the markets in which we invest. In some circumstances, some of our holdings of investment securities may be large enough to have an influence on the market value. These factors may limit our ability to sell these investments or sell them at an adequate price.
2. | Liquidity Uses |
Our principal cash outflows primarily relate to the liabilities associated with our various life insurance, annuity and accident and health insurance products, dividend and interest payments on our insurance policies and annuity contracts, operating expenses, income taxes and dividends that may be declared and paid to our equity holders. Cash outflows arising from our insurance activities primarily relate to benefit payments under these insurance products, as well as payments for policy surrenders, withdrawals and loans.
We believe that our sources of liquidity are sufficient to meet our current cash requirements.
19
Commission File Number 001-31914
3. | Consolidated Cash Flows |
RMB million | ||||||||
January to | January to | |||||||
June 2013 | June 2012 | |||||||
Net cash inflow from operating activities | 42,740 | 53,314 | ||||||
Net cash outflow from investing activities | (45,517 | ) | (73,427 | ) | ||||
Net cash inflow/(outflow) from financing activities | (15,550 | ) | 52,437 | |||||
Foreign currency gains/(losses) on cash and cash equivalents | (12 | ) | 8 | |||||
|
|
|
| |||||
Net increase/(decrease) in cash and cash equivalents | (18,339 | ) | 32,332 | |||||
|
|
|
|
We have established a cash flow testing system, and conduct regular tests to monitor the cash inflows and outflows under various changing circumstances and adjust the asset portfolio accordingly to ensure sufficient sources of liquidity. During the Reporting Period, net cash inflow from operating activities decreased by 19.8% year-on-year. This was primarily due to an increase in insurance claims expenses. Net cash outflow from investing activities decreased by 38.0% year-on-year. This was primarily due to the needs for investment management. The change of net cash inflow/(outflow) from financing activities was primarily due to the needs for liquidity management.
V. | Solvency Ratio |
The solvency ratio of an insurance company is a measure of capital adequacy, which is calculated by dividing the actual capital of the company (which is its admissible assets less admissible liabilities, determined in accordance with relevant rules) by the minimum capital it is required to meet. The following table shows our solvency ratio as at the end of the Reporting Period:
RMB million | ||||||||
As at 30 | As at 31 | |||||||
June 2013 | December 2012 | |||||||
Actual capital | 185,699 | 176,024 | ||||||
Minimum capital | 78,057 | 74,718 | ||||||
Solvency ratio | 237.90 | % | 235.58 | % |
The increase of the Company’s solvency ratio was primarily due to the combined effects of the comprehensive income during the Reporting Period, the distribution of dividend of last year to equity holders and the business development of the Company.
20
Commission File Number 001-31914
INTERIM RESULTS9
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
For the six months ended 30 June 2013
Unaudited | ||||||||||||
For the six months | ||||||||||||
ended 30 June | ||||||||||||
2013 | 2012 | |||||||||||
Notes | RMB million | RMB million | ||||||||||
REVENUES | ||||||||||||
Gross written premiums | 203,251 | 185,438 | ||||||||||
Less: premiums ceded to reinsurers | (285 | ) | (151 | ) | ||||||||
|
|
|
| |||||||||
Net written premiums | 202,966 | 185,287 | ||||||||||
Net change in unearned premium reserves | (2,122 | ) | (548 | ) | ||||||||
|
|
|
| |||||||||
Net premiums earned | 200,844 | 184,739 | ||||||||||
|
|
|
| |||||||||
Investment income | 1 | 40,103 | 35,303 | |||||||||
Net realised gains and impairment on financial assets | 2 | 3,922 | (13,114 | ) | ||||||||
Net fair value gains through profit or loss | 3 | 918 | 177 | |||||||||
Other income | 1,761 | 1,495 | ||||||||||
|
|
|
| |||||||||
Total revenues | 247,548 | 208,600 | ||||||||||
|
|
|
| |||||||||
BENEFITS, CLAIMS AND EXPENSES | ||||||||||||
Insurance benefits and claims expenses | ||||||||||||
Life insurance death and other benefits | (111,690 | ) | (64,175 | ) | ||||||||
Accident and health claims and claim adjustment expenses | (4,688 | ) | (4,010 | ) | ||||||||
Increase in insurance contracts liabilities | (72,869 | ) | (100,229 | ) | ||||||||
Investment contract benefits | (985 | ) | (968 | ) | ||||||||
Policyholder dividends resulting from participation in profits | (9,777 | ) | (2,495 | ) | ||||||||
Underwriting and policy acquisition costs | (13,800 | ) | (14,569 | ) | ||||||||
Finance costs | (1,935 | ) | (891 | ) | ||||||||
Administrative expenses | (10,817 | ) | (9,813 | ) | ||||||||
Other expenses | (2,021 | ) | (1,614 | ) | ||||||||
Statutory insurance fund contribution | (385 | ) | (345 | ) | ||||||||
|
|
|
| |||||||||
Total benefits, claims and expenses | (228,967 | ) | (199,109 | ) | ||||||||
|
|
|
|
9 | The “Group” refers to China Life Insurance Company Limited and its subsidiaries in this part. |
21
Commission File Number 001-31914
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
(CONTINUED)
For the six months ended 30 June 2013
Unaudited | ||||||||||||
For the six months | ||||||||||||
ended 30 June | ||||||||||||
2013 | 2012 | |||||||||||
Notes | RMB million | RMB million | ||||||||||
Share of profit of associates | 1,576 | 1,521 | ||||||||||
|
|
|
| |||||||||
Profit before income tax | 4 | 20,157 | 11,012 | |||||||||
Income tax | 5 | (3,829 | ) | (1,271 | ) | |||||||
|
|
|
| |||||||||
Net profit | 16,328 | 9,741 | ||||||||||
|
|
|
| |||||||||
Attributable to: | ||||||||||||
– equity holders of the Company | 16,198 | 9,635 | ||||||||||
– non-controlling interests | 130 | 106 | ||||||||||
|
|
|
| |||||||||
Basic and diluted earnings per share | 6 | RMB 0.57 | RMB 0.34 | |||||||||
|
|
|
| |||||||||
Other comprehensive income | ||||||||||||
Other comprehensive income to be reclassified to profit or loss in subsequent periods: | ||||||||||||
Fair value gains/(losses) on available-for-sale securities | (2,258 | ) | 11,702 | |||||||||
Amount transferred to net profit from other comprehensive income | (3,922 | ) | 13,115 | |||||||||
Portion of fair value changes on available-for-sale securities attributable to participating policyholders | 2,476 | — | ||||||||||
Share of other comprehensive income of associates under the equity method | 142 | 200 | ||||||||||
Income tax relating to component of other comprehensive income | 898 | (6,194 | ) | |||||||||
|
|
|
| |||||||||
Other comprehensive income to be reclassified to profit or loss in subsequent periods | (2,664 | ) | 18,823 | |||||||||
|
|
|
| |||||||||
Other comprehensive income not being reclassified to profit or loss in subsequent periods | — | — | ||||||||||
|
|
|
| |||||||||
Other comprehensive income for the period | (2,664 | ) | 18,823 | |||||||||
|
|
|
| |||||||||
Total comprehensive income for the period | 13,664 | 28,564 | ||||||||||
|
|
|
| |||||||||
Attributable to: | ||||||||||||
– equity holders of the Company | 13,515 | 28,444 | ||||||||||
– non-controlling interests | 149 | 120 | ||||||||||
|
|
|
|
22
Commission File Number 001-31914
Notes:
1 | INVESTMENT INCOME |
For the six months ended 30 June | ||||||||
2013 | 2012 | |||||||
RMB million | RMB million | |||||||
Debt securities | ||||||||
– held-to-maturity securities | 10,951 | 6,330 | ||||||
– available-for-sale securities | 7,983 | 8,254 | ||||||
– at fair value through profit or loss | 437 | 469 | ||||||
Equity securities | ||||||||
– available-for-sale securities | 1,628 | 2,410 | ||||||
– at fair value through profit or loss | 350 | 367 | ||||||
Bank deposits | 15,937 | 14,959 | ||||||
Loans | 2,642 | 2,027 | ||||||
Securities purchased under agreements to resell | 160 | 487 | ||||||
Others | 15 | — | ||||||
|
|
|
| |||||
Total | 40,103 | 35,303 | ||||||
|
|
|
|
For the six months ended 30 June 2013, included in investment income is interest income of RMB38,125 million (for the six months ended 30 June 2012: RMB32,526 million). All interest income is accrued using the effective interest method.
The investment income from listed debt and equity securities for the six months ended 30 June 2013 was RMB3,355 million (for the six months ended 30 June 2012: RMB3,450 million). The investment income from unlisted debt and equity securities for the six months ended 30 June 2013 was RMB17,994 million (for the six months ended 30 June 2012: RMB14,380 million).
2 | NET REALISED GAINS AND IMPAIRMENT ON FINANCIAL ASSETS |
For the six months ended 30 June | ||||||||
2013 | 2012 | |||||||
RMB million | RMB million | |||||||
Debt securities | ||||||||
Net realised gains (i) | 341 | 967 | ||||||
Reversal of impairment | — | 51 | ||||||
|
|
|
| |||||
Subtotal | 341 | 1,018 | ||||||
|
|
|
| |||||
Equity securities | ||||||||
Net realised gains (i) | 7,277 | 1,036 | ||||||
Impairment (ii) | (3,696 | ) | (15,168 | ) | ||||
|
|
|
| |||||
Subtotal | 3,581 | (14,132 | ) | |||||
|
|
|
| |||||
Total | 3,922 | (13,114 | ) | |||||
|
|
|
|
(i) | Net realised gains on financial assets are from available-for-sale securities. |
(ii) | During the six months ended 30 June 2013, the Group recognised impairment charges of RMB124 million (for the six months ended 30 June 2012: RMB7,029 million) for available-for-sale funds, RMB3,428 million (for the six months ended 30 June 2012: RMB8,139 million) for available-for-sale common stocks and RMB144 million (for the six months ended 30 June 2012: Nil) for other available-for-sale securities, for which the Group determined that objective evidence of impairment existed. |
23
Commission File Number 001-31914
3 | NET FAIR VALUE GAINS THROUGH PROFIT OR LOSS |
For the six months ended 30 June | ||||||||
2013 | 2012 | |||||||
RMB million | RMB million | |||||||
Debt securities | 282 | 225 | ||||||
Equity securities | 319 | (11 | ) | |||||
Stock appreciation rights | 317 | (37 | ) | |||||
|
|
|
| |||||
Total | 918 | 177 | ||||||
|
|
|
|
4 | PROFIT BEFORE INCOME TAX |
Profit before income tax is stated after charging the following:
For the six months ended 30 June | ||||||||
2013 | 2012 | |||||||
RMB million | RMB million | |||||||
Employee salaries and welfare costs | 4,019 | 3,552 | ||||||
Housing benefits | 355 | 288 | ||||||
Contribution to the defined contribution pension plans | 938 | 834 | ||||||
Depreciation and amortisation | 1,015 | 977 | ||||||
Exchange losses/(gains) | 261 | (46 | ) | |||||
|
|
|
|
5 | TAXATION |
Deferred income tax assets and liabilities are offset when there is a legally enforceable right to offset current tax assets against current liabilities and when the deferred income tax relates to the same fiscal authority.
(a) | The amount of taxation charged to net profit represents: |
For the six months ended 30 June | ||||||||
2013 | 2012 | |||||||
RMB million | RMB million | |||||||
Current taxation – Enterprise income tax | 1,231 | 1,231 | ||||||
Deferred taxation | 2,598 | 40 | ||||||
|
|
|
| |||||
Taxation charges | 3,829 | 1,271 | ||||||
|
|
|
|
24
Commission File Number 001-31914
(b) | The reconciliation between the Group’s effective tax rate and the statutory tax rate of 25% in the PRC (for the six months ended 30 June 2012: 25%) is as follows: |
For the six months ended 30 June | ||||||||||||
2013 | 2012 | |||||||||||
RMB million | RMB million | |||||||||||
Profit before income tax | 20,157 | 11,012 | ||||||||||
Tax computed at the statutory tax rate | 5,039 | 2,753 | ||||||||||
Non-taxable income | (i | ) | (1,416 | ) | (1,668 | ) | ||||||
Expenses not deductible for tax purposes | (i | ) | 190 | 166 | ||||||||
Unused tax losses | 32 | 31 | ||||||||||
Others | (16 | ) | (11 | ) | ||||||||
|
|
|
| |||||||||
Income tax at effective tax rate | 3,829 | 1,271 | ||||||||||
|
|
|
|
(i) | Non-taxable income mainly includes interest income from government bonds and funds. Expenses not deductible for tax purposes mainly include commission, brokerage and donation expenses that do not meet the criteria for deduction according to the relevant tax regulations. |
(c) | As at 30 June 2013, deferred income tax was calculated in full on temporary differences under the liability method using a principal tax rate of 25%. The movements in deferred tax assets and liabilities during the period are as follows: |
Deferred tax assets/(liabilities)
Insurance | Investment | Others | Total | |||||||||||||
RMB million | RMB million | RMB million | RMB million | |||||||||||||
(i) | (ii) | (iii) | ||||||||||||||
As at 1 January 2012 | (12,266 | ) | 9,857 | 955 | (1,454 | ) | ||||||||||
(Charged)/credited to net profit | (187 | ) | 542 | (395 | ) | (40 | ) | |||||||||
(Charged)/credited to other comprehensive income | ||||||||||||||||
– Available-for-sale securities | — | (6,194 | ) | — | (6,194 | ) | ||||||||||
|
|
|
|
|
|
|
| |||||||||
As at 30 June 2012 | (12,453 | ) | 4,205 | 560 | (7,688 | ) | ||||||||||
|
|
|
|
|
|
|
| |||||||||
As at 1 January 2013 | (11,787 | ) | 3,061 | 892 | (7,834 | ) | ||||||||||
(Charged)/credited to net profit | 1,016 | (3,291 | ) | (323 | ) | (2,598 | ) | |||||||||
(Charged)/credited to other comprehensive income | ||||||||||||||||
– Available-for-sale securities | — | 1,547 | — | 1,547 | ||||||||||||
– Portion of fair value gains on available-for-sale securities allocated to participating policyholders | (619 | ) | — | — | (619 | ) | ||||||||||
– Others | — | (30 | ) | — | (30 | ) | ||||||||||
|
|
|
|
|
|
|
| |||||||||
As at 30 June 2013 | (11,390 | ) | 1,287 | 569 | (9,534 | ) | ||||||||||
|
|
|
|
|
|
|
|
25
Commission File Number 001-31914
(i) | The deferred tax arising from the insurance category is mainly related to the change of long-term insurance contracts liabilities at 31 December 2008 as a result of the first-time adoption of IFRS in 2009 and the temporary difference of short-term insurance contracts liabilities and policyholder dividend payables. |
(ii) | The deferred tax arising from the investment category is mainly related to the temporary difference of unrealised gains/(losses), which includes available-for-sale securities, securities at fair value through profit or loss, and others. |
(iii) | The deferred tax arising from the other category is mainly related to the temporary difference of employee salary and welfare cost payables. |
(d) | The analysis of deferred tax assets and deferred tax liabilities is as follows: |
As at 30 June 2013 | As at 31 December 2012 | |||||||
RMB million | RMB million | |||||||
Deferred tax assets: | ||||||||
– deferred tax assets to be recovered after more than 12 months | 2,921 | 6,729 | ||||||
– deferred tax assets to be recovered within 12 months | 2,217 | 1,342 | ||||||
|
|
|
| |||||
Subtotal | 5,138 | 8,071 | ||||||
|
|
|
| |||||
Deferred tax liabilities: | ||||||||
– deferred tax liabilities to be settled after more than 12 months | (14,197 | ) | (15,555 | ) | ||||
– deferred tax liabilities to be settled within 12 months | (475 | ) | (350 | ) | ||||
|
|
|
| |||||
Subtotal | (14,672 | ) | (15,905 | ) | ||||
|
|
|
| |||||
Total net deferred tax liabilities | (9,534 | ) | (7,834 | ) | ||||
|
|
|
|
6 | EARNINGS PER SHARE |
There is no difference between basic and diluted earnings per share. The basic and diluted earnings per share for the six months ended 30 June 2013 are based on the weighted average number of 28,264,705,000 ordinary shares (for the six months ended 30 June 2012: 28,264,705,000).
7 | DIVIDENDS |
A dividend in respect of 2012 of RMB0.14 per ordinary share, totalling RMB3,957 million, was approved at the Annual General Meeting in June 2013.
26
Commission File Number 001-31914
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION
As at 30 June 2013
Unaudited As at 30 June 2013 | Audited As at 31 December 2012 | |||||||
RMB million | RMB million | |||||||
ASSETS | ||||||||
Property, plant and equipment | 20,686 | 22,335 | ||||||
Investment properties | 1,352 | — | ||||||
Investments in associates | 30,511 | 28,991 | ||||||
Held-to-maturity securities | 477,350 | 452,389 | ||||||
Loans | 97,339 | 80,419 | ||||||
Term deposits | 690,829 | 641,080 | ||||||
Statutory deposits – restricted | 6,153 | 6,153 | ||||||
Available-for-sale securities | 481,537 | 506,416 | ||||||
Securities at fair value through profit or loss | 43,737 | 34,035 | ||||||
Securities purchased under agreements to resell | 6,109 | 894 | ||||||
Accrued investment income | 34,238 | 28,926 | ||||||
Premiums receivable | 17,524 | 8,738 | ||||||
Reinsurance assets | 1,014 | 948 | ||||||
Other assets | 24,543 | 18,140 | ||||||
Cash and cash equivalents | 51,113 | 69,452 | ||||||
|
|
|
| |||||
Total assets | 1,984,035 | 1,898,916 | ||||||
|
|
|
|
27
Commission File Number 001-31914
CONDENSED CONSOLIDATED STATEMENT OF FINANCIAL POSITION (CONTINUED)
As at 30 June 2013
Unaudited As at 30 June 2013 | Audited As at 31 December 2012 | |||||||
RMB million | RMB million | |||||||
LIABILITIES AND EQUITY | ||||||||
Liabilities | ||||||||
Insurance contracts | 1,459,892 | 1,384,537 | ||||||
Investment contracts | 65,512 | 66,639 | ||||||
Policyholder dividends payable | 46,218 | 44,240 | ||||||
Bonds payable | 67,983 | 67,981 | ||||||
Securities sold under agreements to repurchase | 57,426 | 68,499 | ||||||
Annuity and other insurance balances payable | 26,010 | 16,890 | ||||||
Premiums received in advance | 2,174 | 2,576 | ||||||
Other liabilities | 16,307 | 16,435 | ||||||
Deferred tax liabilities | 9,534 | 7,834 | ||||||
Current income tax liabilities | 18 | 22 | ||||||
Statutory insurance fund | 233 | 162 | ||||||
|
|
|
| |||||
Total liabilities | 1,751,307 | 1,675,815 | ||||||
|
|
|
| |||||
Equity | ||||||||
Share capital | 28,265 | 28,265 | ||||||
Reserves | 110,852 | 112,428 | ||||||
Retained earnings | 91,526 | 80,392 | ||||||
|
|
|
| |||||
Attributable to equity holders of the Company | 230,643 | 221,085 | ||||||
|
|
|
| |||||
Non-controlling interests | 2,085 | 2,016 | ||||||
|
|
|
| |||||
Total equity | 232,728 | 223,101 | ||||||
|
|
|
| |||||
Total liabilities and equity | 1,984,035 | 1,898,916 | ||||||
|
|
|
|
28
Commission File Number 001-31914
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
For the six months ended 30 June 2013
Unaudited | ||||||||||||||||||||
Attributable to equity holders of the Company | ||||||||||||||||||||
Share capital | Reserves | Retained earnings | Non-controlling interests | Total | ||||||||||||||||
RMB million | RMB million | RMB million | RMB million | RMB million | ||||||||||||||||
As at 1 January 2012 | 28,265 | 83,371 | 79,894 | 1,858 | 193,388 | |||||||||||||||
Net profit | — | — | 9,635 | 106 | 9,741 | |||||||||||||||
Other comprehensive income | — | 18,809 | — | 14 | 18,823 | |||||||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
Total comprehensive income | — | 18,809 | 9,635 | 120 | 28,564 | |||||||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
Transactions with owners | ||||||||||||||||||||
Appropriation to reserves | — | 1,848 | (1,848 | ) | — | — | ||||||||||||||
Dividends paid | — | — | (6,501 | ) | — | (6,501 | ) | |||||||||||||
Dividends to non-controlling interests | — | — | — | (65 | ) | (65 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
Total transactions with owners | — | 1,848 | (8,349 | ) | (65 | ) | (6,566 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
As at 30 June 2012 | 28,265 | 104,028 | 81,180 | 1,913 | 215,386 | |||||||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
As at 1 January 2013 | 28,265 | 112,428 | 80,392 | 2,016 | 223,101 | |||||||||||||||
Net profit | — | — | 16,198 | 130 | 16,328 | |||||||||||||||
Other comprehensive income | — | (2,683 | ) | — | 19 | (2,664 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
Total comprehensive income | — | (2,683 | ) | 16,198 | 149 | 13,664 | ||||||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
Transactions with owners | ||||||||||||||||||||
Appropriation to reserves | — | 1,107 | (1,107 | ) | — | — | ||||||||||||||
Dividends paid | — | — | (3,957 | ) | — | (3,957 | ) | |||||||||||||
Dividends to non-controlling interests | — | — | — | (80 | ) | (80 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
Total transactions with owners | — | 1,107 | (5,064 | ) | (80 | ) | (4,037 | ) | ||||||||||||
|
|
|
|
|
|
|
|
|
| |||||||||||
As at 30 June 2013 | 28,265 | 110,852 | 91,526 | 2,085 | 232,728 | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
29
Commission File Number 001-31914
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
For the six months ended 30 June 2013
Unaudited For the six months ended 30 June | ||||||||
2013 | 2012 | |||||||
RMB million | RMB million | |||||||
Net cash inflow from operating activities | 42,740 | 53,314 | ||||||
Net cash outflow from investing activities | (45,517 | ) | (73,427 | ) | ||||
Net cash inflow/(outflow) from financing activities | (15,550 | ) | 52,437 | |||||
Foreign currency gains/(losses) on cash and cash equivalents | (12 | ) | 8 | |||||
|
|
|
| |||||
Net increase/(decrease) in cash and cash equivalents | (18,339 | ) | 32,332 | |||||
|
|
|
| |||||
Cash and cash equivalents | ||||||||
Beginning of period | 69,452 | 55,985 | ||||||
|
|
|
| |||||
End of period | 51,113 | 88,317 | ||||||
|
|
|
| |||||
Analysis of balance of cash and cash equivalents | ||||||||
Cash at bank and in hand | 51,109 | 84,333 | ||||||
Short-term bank deposits | 4 | 3,984 |
30
Commission File Number 001-31914
SEGMENT INFORMATION
1 | Operating segments |
The Group operates in five operating segments:
(i) | Individual life insurance business (Individual life) |
Individual life insurance business relates primarily to the sale of long-term life insurance contracts and universal life contracts which are mainly term life, whole life, endowment and annuity products, to individuals.
(ii) | Group life insurance business (Group life) |
Group life insurance business relates primarily to the sale of long-term life insurance contracts and investment contracts, which are mainly term life, whole life and annuity products, to group entities.
(iii) | Short-term insurance business (Short-term) |
Short-term insurance business relates primarily to the sale of short-term insurance contracts, which are mainly the short-term accident and health insurance contracts (excluding supplementary major medical insurance business).
(iv) | Supplementary major medical insurance business (Supplementary major medical) |
Supplementary major medical insurance business relates primarily to the sale of supplementary major medical insurance contracts to urban and rural residents according to the “Interim Administrative Measures on the Supplementary Major Medical Insurance for Urban and Rural Residents of Insurance Companies” issued by the CIRC.
(v) | Other business (Other) |
Other business relates primarily to income and allocated cost of insurance agency business in respect of the provision of services to China Life Insurance (Group) Company, share of results of associates, income and expenses of subsidiaries, unallocated income and expenditure of the Group.
31
Commission File Number 001-31914
2 | Allocation basis of income and expenses |
Investment income, net realised gains and impairment on financial assets, net fair value gains through profit or loss and foreign exchange gains or losses within other expenses are allocated across segments in proportion to respective segment’s average liabilities of insurance contracts and investment contracts at the beginning and end of the period. Administrative expenses and certain other expenses are allocated across segments in proportion to the unit cost of respective products in the different segments. Except for amounts arising from investment contracts which can be allocated to the corresponding segments above, other income and other expenses are presented in the “Other” segment directly. Income tax is not allocated.
32
Commission File Number 001-31914
For the six months ended 30 June 2013 | ||||||||||||||||||||||||||||
Individual life | Group life | Short-term | Supplementary Major Medical | Other | Elimination | Total | ||||||||||||||||||||||
(RMB million) | ||||||||||||||||||||||||||||
Revenues | ||||||||||||||||||||||||||||
Gross written premiums | 191,186 | 1,027 | 9,770 | 1,268 | — | — | 203,251 | |||||||||||||||||||||
– Term life | 1,219 | 388 | — | — | — | — | ||||||||||||||||||||||
– Whole life | 18,129 | 32 | — | — | — | — | ||||||||||||||||||||||
– Endowment | 138,953 | — | — | — | — | — | ||||||||||||||||||||||
– Annuity | 32,885 | 607 | — | — | — | — | ||||||||||||||||||||||
Net premiums earned | 191,104 | 1,023 | 8,197 | 520 | — | — | 200,844 | |||||||||||||||||||||
Investment income | 38,203 | 1,511 | 260 | — | 129 | — | 40,103 | |||||||||||||||||||||
Net realised gains and impairment on financial assets | 3,739 | 148 | 25 | — | 10 | — | 3,922 | |||||||||||||||||||||
Net fair value gains through profit or loss | 893 | 35 | 6 | — | (16 | ) | — | 918 | ||||||||||||||||||||
Other income | 211 | 277 | — | — | 1,707 | (434 | ) | 1,761 | ||||||||||||||||||||
Including: inter-segment revenue | — | — | — | — | 434 | (434 | ) | — | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Segment revenues | 234,150 | 2,994 | 8,488 | 520 | 1,830 | (434 | ) | 247,548 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Benefits, claims and expenses | ||||||||||||||||||||||||||||
Insurance benefits and claims expenses | ||||||||||||||||||||||||||||
Life insurance death and other benefits | (111,428 | ) | (262 | ) | — | — | — | — | (111,690 | ) | ||||||||||||||||||
Accident and health claims and claim adjustment expenses | — | — | (4,137 | ) | (551 | ) | — | — | (4,688 | ) | ||||||||||||||||||
Increase in insurance contracts liabilities | (72,128 | ) | (741 | ) | — | — | — | — | (72,869 | ) | ||||||||||||||||||
Investment contract benefits | (222 | ) | (763 | ) | — | — | — | — | (985 | ) | ||||||||||||||||||
Policyholder dividends resulting from participation in profits | (9,144 | ) | (633 | ) | — | — | — | — | (9,777 | ) | ||||||||||||||||||
Underwriting and policy acquisition costs | (11,573 | ) | (58 | ) | (1,815 | ) | — | (354 | ) | — | (13,800 | ) | ||||||||||||||||
Finance costs | (1,849 | ) | (73 | ) | (13 | ) | — | — | — | (1,935 | ) | |||||||||||||||||
Administrative expenses | (7,821 | ) | (287 | ) | (1,814 | ) | (42 | ) | (853 | ) | — | (10,817 | ) | |||||||||||||||
Other expenses | (1,640 | ) | (37 | ) | (389 | ) | — | (389 | ) | 434 | (2,021 | ) | ||||||||||||||||
Including: Inter-segment expenses | (415 | ) | (16 | ) | (3 | ) | — | — | 434 | — | ||||||||||||||||||
Statutory insurance fund contribution | (300 | ) | (11 | ) | (72 | ) | (2 | ) | — | — | (385 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Segment benefits, claims and expenses | (216,105 | ) | (2,865 | ) | (8,240 | ) | (595 | ) | (1,596 | ) | 434 | (228,967 | ) | |||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Share of profit of associates | — | — | — | — | 1,576 | — | 1,576 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Segment results | 18,045 | 129 | 248 | (75 | ) | 1,810 | — | 20,157 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Income tax | (3,829 | ) | ||||||||||||||||||||||||||
|
| |||||||||||||||||||||||||||
Net profit | 16,328 | |||||||||||||||||||||||||||
|
| |||||||||||||||||||||||||||
Other comprehensive income attributable to equity holders of the Company | (2,602 | ) | (103 | ) | (18 | ) | — | 40 | — | (2,683 | ) | |||||||||||||||||
Depreciation and amortisation | 763 | 28 | 183 | 4 | 37 | — | 1,015 |
33
Commission File Number 001-31914
For the six months ended 30 June 2012 | ||||||||||||||||||||||||||||
Individual life | Group life | Short-term | Supplementary Major Medical | Other | Elimination | Total | ||||||||||||||||||||||
(RMB million) | ||||||||||||||||||||||||||||
Revenues | ||||||||||||||||||||||||||||
Gross written premiums | 176,499 | 316 | 8,623 | — | — | — | 185,438 | |||||||||||||||||||||
– Term life | 1,020 | 294 | — | — | — | — | ||||||||||||||||||||||
– Whole life | 18,752 | 21 | — | — | — | — | ||||||||||||||||||||||
– Endowment | 135,322 | — | — | — | — | — | ||||||||||||||||||||||
– Annuity | 21,405 | 1 | — | — | — | — | ||||||||||||||||||||||
Net premiums earned | 176,483 | 315 | 7,941 | — | — | — | 184,739 | |||||||||||||||||||||
Investment income | 33,439 | 1,506 | 239 | — | 119 | — | 35,303 | |||||||||||||||||||||
Net realised gains and impairment on financial assets | (12,457 | ) | (561 | ) | (90 | ) | — | (6 | ) | — | (13,114 | ) | ||||||||||||||||
Net fair value gains through profit or loss | 167 | 8 | 1 | — | 1 | — | 177 | |||||||||||||||||||||
Other income | 183 | 194 | — | — | 1,495 | (377 | ) | 1,495 | ||||||||||||||||||||
Including: inter-segment revenue | — | — | — | — | 377 | (377 | ) | — | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Segment revenues | 197,815 | 1,462 | 8,091 | — | 1,609 | (377 | ) | 208,600 | ||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Benefits, claims and expenses | ||||||||||||||||||||||||||||
Insurance benefits and claims expenses | ||||||||||||||||||||||||||||
Life insurance death and other benefits | (64,007 | ) | (168 | ) | — | — | — | — | (64,175 | ) | ||||||||||||||||||
Accident and health claims and claim adjustment expenses | — | — | (4,010 | ) | — | — | — | (4,010 | ) | |||||||||||||||||||
Increase in insurance contracts liabilities | (100,139 | ) | (90 | ) | — | — | — | — | (100,229 | ) | ||||||||||||||||||
Investment contract benefits | (260 | ) | (708 | ) | — | — | — | — | (968 | ) | ||||||||||||||||||
Policyholder dividends resulting from participation in profits | (2,468 | ) | (27 | ) | — | — | — | — | (2,495 | ) | ||||||||||||||||||
Underwriting and policy acquisition costs | (12,616 | ) | (48 | ) | (1,640 | ) | — | (265 | ) | — | (14,569 | ) | ||||||||||||||||
Finance costs | (681 | ) | (24 | ) | (184 | ) | — | (2 | ) | — | (891 | ) | ||||||||||||||||
Administrative expenses | (6,830 | ) | (238 | ) | (1,792 | ) | — | (953 | ) | — | (9,813 | ) | ||||||||||||||||
Other expenses | (1,534 | ) | (62 | ) | (147 | ) | — | (248 | ) | 377 | (1,614 | ) | ||||||||||||||||
Including: Inter-segment expenses | (358 | ) | (16 | ) | (3 | ) | — | — | 377 | — | ||||||||||||||||||
Statutory insurance fund contribution | (265 | ) | (9 | ) | (71 | ) | — | — | — | (345 | ) | |||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Segment benefits, claims and expenses | (188,800 | ) | (1,374 | ) | (7,844 | ) | — | (1,468 | ) | 377 | (199,109 | ) | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Share of profit of associates | — | — | — | — | 1,521 | — | 1,521 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Segment results | 9,015 | 88 | 247 | — | 1,662 | — | 11,012 | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||||||||||
Income tax | (1,271 | ) | ||||||||||||||||||||||||||
|
| |||||||||||||||||||||||||||
Net profit | 9,741 | |||||||||||||||||||||||||||
|
| |||||||||||||||||||||||||||
Other comprehensive income attributable to equity holders of the Company | 17,815 | 802 | 127 | — | 65 | — | 18,809 | |||||||||||||||||||||
Depreciation and amortisation | 718 | 25 | 194 | — | 40 | — | 977 |
34
Commission File Number 001-31914
EMBEDDED VALUE
Summary of Results
The embedded value as at 30 June 2013 and the corresponding results as at 31 December 2012 are shown below:
Table 1
Components of Embedded Value | RMB million | |||||||||
30 June | 31 December | |||||||||
ITEM | 2013 | 2012 | ||||||||
A | Adjusted Net Worth | 139,846 | 128,507 | |||||||
B | Value of In-Force Business before Cost of Solvency Margin | 261,005 | 245,134 | |||||||
C | Cost of Solvency Margin | (37,491 | ) | (36,046 | ) | |||||
D | Value of In-Force Business after Cost of Solvency Margin (B+C) | 223,514 | 209,088 | |||||||
E | Embedded Value (A + D) | 363,359 | 337,596 |
Notes: | 1) | Numbers may not be additive due to rounding. | ||
2) | Taxable income is based on earnings calculated using solvency reserves. |
The value of half year’s sales for the six months ended 30 June 2013 and for the corresponding period of last year:
Table 2
Components of Value of Half Year’s Sales | RMB million | |||||||||
30 June | 30 June | |||||||||
ITEM | 2013 | 2012 | ||||||||
A | Value of Half Year’s Sales before Cost of Solvency Margin | 14,489 | 14,364 | |||||||
B | Cost of Solvency Margin | (1,900 | ) | (1,870 | ) | |||||
C | Value of Half Year’s Sales after Cost of Solvency Margin (A + B) | 12,589 | 12,494 |
Note: | Taxable income is based on earnings calculated using solvency reserves. |
35
Commission File Number 001-31914
MOVEMENT ANALYSIS
The following analysis tracks the movement of the embedded value from the start to the end of the Reporting Period.
Table 3
Analysis of Embedded Value Movement in the First Half Year of 2013 | RMB million | |||
ITEM | ||||
A Embedded Value at Start of Year | 337,596 | |||
B Expected Return on Embedded Value | 16,721 | |||
C Value of New Business in the Period | 12,589 | |||
D Operating Experience Variance | 5 | |||
E Investment Experience Variance | (3,277 | ) | ||
F Methodology and Model Changes | (363 | ) | ||
G Market Value and Other Adjustments | 3,426 | |||
H Exchange Gains or Losses | (260 | ) | ||
I Shareholder Dividend Distribution | (3,957 | ) | ||
J Other | 881 | |||
K Embedded Value as at 30 June 2013 (sum A through J) | 363,359 |
Notes: | 1) | Numbers may not be additive due to rounding. | ||||||
2) | Items B through J are explained below: | |||||||
B | Reflects unwinding of the opening value of in-force business and value of new business sales in the first half | |||||||
year of 2013 plus the expected return on investments supporting the 2013 opening net worth. | ||||||||
C | Value of new business sales in the first half year of 2013. | |||||||
D | Reflects the difference between actual operating experience in the first half year of 2013 (including mortality, morbidity, lapse, and expense etc.) and the assumptions. | |||||||
E | Compares actual with expected investment returns during the first half year of 2013. | |||||||
F | Reflects the effect of projection method and model enhancements. | |||||||
G | Reflects the change in the market value adjustment from the beginning of year 2013 to 30 June 2013, and other related adjustments. | |||||||
H | Reflects the gains or losses due to change in exchange rate. | |||||||
I | Reflects dividends distributed to shareholders during 2013. | |||||||
J | Other miscellaneous items. |
36
Commission File Number 001-31914
SENSITIVITY RESULTS
Sensitivity testing was performed using a range of alternative assumptions. In each of the sensitivity tests, only the assumption referred to was changed, with all other assumptions remaining unchanged. The results are summarized below:
Table 4
Sensitivity Results | RMB million | |||||||||
VALUE OF | VALUE OF HALF | |||||||||
IN-FORCE BUSINESS | YEAR’S SALES | |||||||||
AFTER COST OF | AFTER COST OF | |||||||||
SOLVENCY MARGIN | SOLVENCY MARGIN | |||||||||
Base case scenario | 223,514 | 12,589 | ||||||||
1. | Risk discount rate of 11.5% | 212,659 | 11,928 | |||||||
2. | Risk discount rate of 10.5% | 235,171 | 13,298 | |||||||
3. | 10% increase in investment return | 260,723 | 14,242 | |||||||
4. | 10% decrease in investment return | 186,568 | 10,956 | |||||||
5. | 10% increase in expenses | 220,881 | 11,650 | |||||||
6. | 10% decrease in expenses | 226,147 | 13,528 | |||||||
7. | 10% increase in mortality rate for non-annuity products and 10% decrease in mortality rate for annuity products | 221,547 | 12,542 | |||||||
8. | 10% decrease in mortality rate for non-annuity products and 10% increase in mortality rate for annuity products | 225,531 | 12,637 | |||||||
9. | 10% increase in lapse rates | 222,342 | 12,484 | |||||||
10. | 10% decrease in lapse rates | 224,724 | 12,695 | |||||||
11. | 10% increase in morbidity rates | 221,414 | 12,535 | |||||||
12. | 10% decrease in morbidity rates | 225,634 | 12,643 | |||||||
13. | 10% increase in claim ratio of short term business | 223,130 | 12,185 | |||||||
14. | 10% decrease in claim ratio of short term business | 223,898 | 12,993 | |||||||
15. | Solvency margin at 150% of statutory minimum | 213,238 | 11,604 | |||||||
16. | Taxable income based on the accounting profit in accordance to the “Provisions on the Accounting Treatment Related to Insurance Contracts” under one possible scenario | 226,245 | 11,956 |
Note: | Taxable income is based on earnings calculated using solvency reserves for Scenarios 1 to 15. |
37
Commission File Number 001-31914
CORPORATE GOVERNANCE
In the first half of 2013, the Company adhered strictly to the regulatory requirements and listing rules of the jurisdictions where it is listed, and adopted effective measures to improve the efficiency of the Board of Directors, strengthen the communication with investors, standardize and upgrade the system and workflow of information disclosure, and increase the transparency of its business operations so as to ensure that investors, especially small and medium investors, have an equal access to the Company’s information.
The Company has applied the principles of the Corporate Governance Code (the “CG Code”) as set out in Appendix 14 to the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “Listing Rules”), and has complied with all code provisions of the CG Code during the Reporting Period.
DIVIDEND
The Company will not declare an interim dividend for the Reporting Period.
PURCHASE, SALE OR REDEMPTION OF THE COMPANY’S SECURITIES
For the Reporting Period, the Company and its subsidiaries did not purchase, sell or redeem any of the Company’s listed securities.
COMPLIANCE WITH THE CODE FOR SECURITIES TRANSACTIONS BY DIRECTORS AND SUPERVISORS OF THE COMPANY
The Board has established written guidelines on no less exacting terms than the Model Code for Securities Transactions by Directors of Listed Issuers (the “Model Code”) as set out in Appendix 10 to the Listing Rules for Directors and Supervisors in respect of their dealings in the securities of the Company. After making specific inquiries to all the Directors and Supervisors of the Company, they confirmed that they had complied with the Model Code and the Company’s own guidelines during the Reporting Period.
38
Commission File Number 001-31914
REVIEW OF ACCOUNTS
The Audit Committee together with external auditors engaged by the Company has reviewed the unaudited consolidated financial statements of the Company for the six months ended 30 June 2013.
PUBLICATION OF INTERIM REPORT
The Company’s interim report will be published on the Company’s website (http://www.e-chinalife.com) and the HKExnews website of the Hong Kong Exchanges and Clearing Limited (http://www.hkexnews.hk) in due course.
This announcement is published in both English and Chinese languages. Should there be any inconsistency between the Chinese and English versions, the Chinese version shall prevail.
As at the date of this announcement, the Directors of the Company are as follows:
Executive Directors: | Mr. Yang Mingsheng, Mr. Wan Feng, Mr. Lin Dairen, | |
Ms. Liu Yingqi | ||
Non-executive Directors: | Mr. Miao Jianmin, Mr. Zhang Xiangxian, Mr. Wang Sidong | |
Independent Non-executive Directors: | Mr. Sun Changji, Mr. Bruce Douglas Moore, | |
Mr. Anthony Francis Neoh, Mr. Tang Jianbang |
By Order of the Board of |
CHINA LIFE INSURANCE COMPANY LIMITED Yang Mingsheng |
Chairman |
Beijing, China, 28 August 2013
39